Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMMUNOCANDIDA Candida Host Defense Response After Septic Shock in the Critically Ill

NCT03136081 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03136081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03136081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMMUNOCANDIDA Candida Host Defense Response After Septic Shock in the Critically Ill
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
May 31, 2015
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

candidiasis, septic shock